Article Details
Retrieved on: 2022-08-16 05:37:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Swiss-headquarterd Novartis AG has reported two cases of fatal liver failure after treatment with the gene therapy Zolgensma.
Article found on: european-biotechnology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here